CoChat

Predicting late recurrence in surgically treated patients with Cushing's disease

Barbot, Mattia, Albiger, Nora, Koutroumpi, Stavroula, Ceccato, Filippo, Frigo, Anna C., Manara, Renzo, Fassina, Ambrogio, Gardiman, Marina P., Scanarini, Massimo, Mantero, Franco, Scaroni, Carla · 2013 · Clinical Endocrinology
Cited by 51

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: Objective: Cushing's disease (CD) has an uncertain prognosis because patients achieving remission after transsphenoidal pituitary neurosurgery (TSS) may relapse. We aimed to identify factors predicting relapse, focusing on desmopressin (DDAVP) and corticotropin‐releasing hormone (CRH) tests after surgery. Materials and methods: Fifty‐seven patients with CD (mean age 36 years) after TSS experienced remission (24 cases), late relapse (LR) (15 cases), or persistent disease (18 cases). Results: The median time to relapse was 40 months. ACTH levels increased after both DDAVP and CRH stimulation, with a significantly higher response in the late recurrence group, showing this to be an indicator of increased risk of relapse. In the logistic regression model, a rise in ACTH >9 pg/ml after DDAVP and >36·7 pg/ml after CRH showed a sensitivity of 93% and 73%, respectively, a specificity of 82% and 76% in LR group. The area under the curve was 0·91 for DDAVP, 0·80 for CRH and 0·95 for DDAVP+CRH test, i.e. the combined tests performed better than each test alone, but not to a statistically significant degree. A response to both tests resulted in a positive predictive value (PPV) of 100%, while no response to either test in a negative predictive value (NPV) of 100%. Conclusions: ACTH hyper‐responsiveness to DDAVP stimulation proved a valuable indicator of relapsing patients with high sensitivity and specificity; in selected cases when a clear high increment of ACTH level is not evident, the CRH test might be used as additional tool to confirm the risk of future relapses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cen.12133

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 51

Metadata

Authors
Barbot, M., Albiger, N., Koutroumpi, S., Ceccato, F., Frigo, A. C., Manara, R., Fassina, A., Gardiman, M. P., Scanarini, M., Mantero, F., & Scaroni, C.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2013-05-06
Volume
79
Issue
3
Pages
394-401
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2042226062
Cited by
51
References
2
FWCI
2.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predicting late recurrence in surgically treated patients with Cushing's disease. https://app.cochat.ai/papers/10.1111/cen.12133
The paper
Barbot, M., Albiger, N., Koutroumpi, S., Ceccato, F., Frigo, A. C., Manara, R., Fassina, A., Gardiman, M. P., Scanarini, M., Mantero, F., & Scaroni, C. (2013). Predicting late recurrence in surgically treated patients with Cushing's disease. Clinical Endocrinology. https://doi.org/10.1111/cen.12133

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.